Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Alvotech - Ordinary Shares
(NQ:
ALVO
)
3.655
+0.125 (+3.54%)
Streaming Delayed Price
Updated: 3:42 PM EDT, Apr 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
151,459
Open
3.560
Bid (Size)
3.650 (700)
Ask (Size)
3.660 (700)
Prev. Close
3.530
Today's Range
3.560 - 3.670
52wk Range
3.030 - 11.85
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Wondering what's happening in today's after-hours session?
↗
April 07, 2026
Via
Chartmill
Alvotech Files Annual Report with the SEC
March 30, 2026
From
Alvotech
Via
GlobeNewswire
Performance
YTD
-26.9%
-26.9%
1 Month
+1.2%
+1.2%
3 Month
-24.3%
-24.3%
6 Month
-57.0%
-57.0%
1 Year
-57.2%
-57.2%
More News
Read More
Alvotech (NASDAQ:ALVO) Reports Q4 Revenue Beat but Significant EPS Miss, Stock Falls on Weak Guidance
↗
March 18, 2026
Via
Chartmill
Alvotech Q4 2025 and Full Year 2025 Financial Results
March 18, 2026
From
Alvotech
Via
GlobeNewswire
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results
March 04, 2026
From
Alvotech
Via
GlobeNewswire
ALVO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alvotech
February 23, 2026
From
Kirby McInerney LLP
Via
GlobeNewswire
Why Is ALVO Stock Rising Pre-Market Today?
↗
February 05, 2026
Via
Stocktwits
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
February 05, 2026
From
Alvotech
Via
GlobeNewswire
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
February 02, 2026
From
Alvotech
Via
GlobeNewswire
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg
January 29, 2026
From
Alvotech
Via
GlobeNewswire
The High-Stakes Balancing Act: Johnson & Johnson Braces for Q4 Earnings Amid Patent Cliffs and MedTech Expansion
January 20, 2026
Via
MarketMinute
Topics
Bankruptcy
Earnings
Economy
Bragar Eagel & Squire, P.C. Continues Investigations into Alvotech and Beyond Meat on Behalf of Stockholders and Encourages Investors to Contact the Firm
January 13, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
January 09, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
January 06, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
Alvotech announces planned CEO succession and leadership transition
January 06, 2026
From
Alvotech
Via
GlobeNewswire
ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP
January 05, 2026
From
Kirby McInerney LLP
Via
Business Wire
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
January 01, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
Alvotech Secures Term Loan Facility of USD 100 Million
December 31, 2025
From
Alvotech
Via
GlobeNewswire
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma
December 22, 2025
From
Alvotech
Via
GlobeNewswire
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
December 19, 2025
From
Teva Pharmaceutical Industries Ltd
Via
GlobeNewswire
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
December 16, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Continues Investigations into Beyond Meat and Alvotech on Behalf of Stockholders and Encourages Investors to Contact the Firm
December 15, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
December 12, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
December 09, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
December 06, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Frequently Asked Questions
Is Alvotech - Ordinary Shares publicly traded?
Yes, Alvotech - Ordinary Shares is publicly traded.
What exchange does Alvotech - Ordinary Shares trade on?
Alvotech - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alvotech - Ordinary Shares?
The ticker symbol for Alvotech - Ordinary Shares is ALVO on the Nasdaq Stock Market
What is the current price of Alvotech - Ordinary Shares?
The current price of Alvotech - Ordinary Shares is 3.655
When was Alvotech - Ordinary Shares last traded?
The last trade of Alvotech - Ordinary Shares was at 04/15/26 03:42 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
